Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

September 30, 2020

Primary Completion Date

January 21, 2022

Study Completion Date

January 21, 2022

Conditions

Healthy VolunteersDiabetic Neuropathies

Interventions

DRUG

BIIB095

Administered as specified in the treatment arm.

DRUG

BIIB074

Administered as specified in the treatment arm.

DRUG

Placebo

Administered as specified in the treatment arm.

DRUG

Lidocaine

Administered as specified in the treatment arm.